Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024–2025
Emerging Infectious Diseases · 2025-12 · 31 (12)
DOI: 10.3201/eid3112.250872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-12. Verfasst von Zareen Fatima und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Macrolides, Pneumonia, Mycoplasma, Drug Resistance, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We investigated macrolide resistance and P1 genotypes of Mycoplasma pneumoniae during the 2024-2025 outbreak in Hamilton, Ontario, Canada. Macrolide resistance remained stable at ≈10%-20%, but significant shifts in P1 genotype distribution and resistance rates in P1 types occurred, indicating notable changes in M. pneumoniae molecular epidemiology in Ontario since 2011-2012.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Fatima, Z., Jayaratne, P., Arrabi, A., Rutherford, C., Leto, D., Smieja, M., & Hasan, M. R. (2025). Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024–2025. Emerging Infectious Diseases, 31(12). https://doi.org/10.3201/eid3112.250872
Vancouver
Fatima Z, Jayaratne P, Arrabi A, Rutherford C, Leto D, Smieja M, et al. Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024–2025. Emerging Infectious Diseases. 2025;31(12). doi:10.3201/eid3112.250872
BibTeX
@article{Fatima2025,
author = {Fatima, Zareen and Jayaratne, Padman and Arrabi, Amjad and Rutherford, Candy and Leto, Daniela and Smieja, Marek and Hasan, Mohammad Rubayet},
title = {Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024–2025},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {12},
doi = {10.3201/eid3112.250872}
}
EUVIMED